215 related articles for article (PubMed ID: 8073823)
21. Morphologic changes in epidermis of PUVA-treated patients with psoriasis with or without a history of arsenic therapy.
Niemi KM; Niemi A; Kanerva L
Arch Dermatol; 1983 Nov; 119(11):904-9. PubMed ID: 6639110
[TBL] [Abstract][Full Text] [Related]
22. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
23. The demonstration of changes in bulbar conjunctiva surface epithelium in the psoriatic patients treated with PUVA.
Söker S; Nergiz Y; Cakmak S; Bahçeci S; Aytekin S
Ann Ophthalmol (Skokie); 2008; 40(2):94-8. PubMed ID: 19013916
[TBL] [Abstract][Full Text] [Related]
24. [Long-term effects of PUVA therapy on Israeli patients with vitiligo].
Vussuki E; Ziv M; Rosenman D; David M
Harefuah; 2006 Jul; 145(7):483-5, 552, 551. PubMed ID: 16900734
[TBL] [Abstract][Full Text] [Related]
25. [PUVA therapy: long-term degenerative effects. II. Study of ultrastructural changes in the skin induced by PUVA therapy].
Torras H; Bombi JA
Med Cutan Ibero Lat Am; 1987; 15(3):179-84. PubMed ID: 3312860
[TBL] [Abstract][Full Text] [Related]
26. A combination therapy of calcipotriol cream and PUVA reduces the UVA dose and improves the response of psoriasis vulgaris.
Torras H; Aliaga A; López-Estebaranz JL; Hernández I; Gardeazabal J; Quintanilla E; Mascaró JM
J Dermatolog Treat; 2004 Apr; 15(2):98-103. PubMed ID: 15204160
[TBL] [Abstract][Full Text] [Related]
27. [Alpha 1-fetoprotein--a marker of potential PUVA side-effects in psoriasis?].
Wollina U; Schulze M; Schaarschmidt H; Barta U; Pfeiffer L; Knopf B; Horn A
Z Hautkr; 1985 Mar; 60(6):527-30. PubMed ID: 2581382
[TBL] [Abstract][Full Text] [Related]
28. Usefulness of surface topography analysis in psoriatic skin.
Monti M; Bozzetti M; Motta S; Barbareschi M
Acta Derm Venereol Suppl (Stockh); 1989; 146():81-3. PubMed ID: 2609892
[TBL] [Abstract][Full Text] [Related]
29. Effects of PUVA therapy on skin surface lipids: skin surface lipid peroxidation in psoriasis vulgaris and its biological significance.
Hayakawa K; Matsuo I
Tokai J Exp Clin Med; 1986 Nov; 11(5):317-22. PubMed ID: 3672560
[TBL] [Abstract][Full Text] [Related]
30. Comparative study of human papilloma virus in untreated and ultraviolet-treated psoriatic patients.
Salem SA; Zuel-Fakkar NM; Fathi G; Abd El-Reheem SM; Abd El-monem El-Tabakh A; Ragab DM
Photodermatol Photoimmunol Photomed; 2010 Apr; 26(2):78-82. PubMed ID: 20415738
[TBL] [Abstract][Full Text] [Related]
31. Twice- vs. thrice-weekly MPD PUVA in psoriasis: a randomized-controlled efficacy study.
Valbuena MC; Hernández O; Rey M; Sánchez G; de Quintana LP
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):126-9. PubMed ID: 17598865
[TBL] [Abstract][Full Text] [Related]
32. Antinuclear antibodies appearing during PUVA therapy.
Bruze M; Ljunggren B
Acta Derm Venereol; 1985; 65(1):31-6. PubMed ID: 2578703
[TBL] [Abstract][Full Text] [Related]
33. Histologic alterations of psoralen- and longwave ultraviolet radiation-exposed skin.
Harrist TJ; Gonzalez E
Natl Cancer Inst Monogr; 1984 Dec; 66():197-204. PubMed ID: 6531029
[TBL] [Abstract][Full Text] [Related]
34. Discrepant levels of vascular endothelial growth factor in psoriasis patients treated with PUVA, Re-PUVA and narrow-band UVB.
Akman A; Dicle O; Yilmaz F; Coskun M; Yilmaz E
Photodermatol Photoimmunol Photomed; 2008 Jun; 24(3):123-7. PubMed ID: 18477130
[TBL] [Abstract][Full Text] [Related]
35. Bath PUVA and saltwater baths followed by UV-B phototherapy as treatments for psoriasis: a randomized controlled trial.
Schiener R; Brockow T; Franke A; Salzer B; Peter RU; Resch KL
Arch Dermatol; 2007 May; 143(5):586-96. PubMed ID: 17519218
[TBL] [Abstract][Full Text] [Related]
36. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
37. Randomized double-blind trial of the treatment of chronic plaque psoriasis: efficacy of psoralen-UV-A therapy vs narrowband UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TT; Hawk JL
Arch Dermatol; 2006 Jul; 142(7):836-42. PubMed ID: 16847198
[TBL] [Abstract][Full Text] [Related]
38. Ocular side effects of PUVA-treated patients refusing eye sun protection.
Calzavara-Pinton PG; Carlino A; Manfredi E; Semeraro F; Zane C; De Panfilis G
Acta Derm Venereol Suppl (Stockh); 1994; 186():164-5. PubMed ID: 8073824
[TBL] [Abstract][Full Text] [Related]
39. PUVA irradiation restores altered binding patterns of lectins in psoriatic epidermis.
Danno K; Yoneda K; Horio T
Arch Dermatol; 1986 Jul; 122(7):772-8. PubMed ID: 2425750
[TBL] [Abstract][Full Text] [Related]
40. Deactivation of endothelium and reduction in angiogenesis in psoriatic skin and synovium by low dose infliximab therapy in combination with stable methotrexate therapy: a prospective single-centre study.
Goedkoop AY; Kraan MC; Picavet DI; de Rie MA; Teunissen MB; Bos JD; Tak PP
Arthritis Res Ther; 2004; 6(4):R326-34. PubMed ID: 15225368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
